Medicine and Dentistry
Patient
100%
Fluorine-18
72%
Parkinson's Disease
72%
Tau
62%
Positron Emission Tomography
45%
Alzheimer's Disease
38%
Brain
25%
Amyloid
25%
Dopamine Agonist
24%
Inpatient
21%
Magnetic Resonance Imaging
21%
Parkinsonism
21%
Flortaucipir
20%
Standardized Uptake Value
20%
Age
15%
Unified Parkinson's Disease Rating Scale
15%
Gait
14%
Carbon 11
14%
Association
14%
Neurology
14%
Dopamine
13%
Drug
13%
Chemotherapeutic Agent
13%
Mild Cognitive Impairment
12%
Putamen
12%
Cognitive Defect
12%
Mitochondrial Membrane Transport Protein
11%
Deterioration
11%
Monoamine
11%
Dopamine Transporter
10%
Temporal Lobe
10%
Time Perception
10%
Perceptive Discrimination
10%
Thalamus
9%
Symptom
8%
Basal Ganglia
8%
Dementia
8%
Florbetaben (18F)
8%
Bradykinesia
8%
Pathology
8%
DNA Template
7%
Progressive Supranuclear Palsy
7%
Tremor
7%
Analysis
7%
Nortropane Derivative
7%
Globus pallidus
7%
Cerebellum
7%
Finger
7%
Hospital
7%
Dyskinesia
7%
Neuroscience
Parkinson's Disease
89%
Amyloid
31%
Positron Emission Tomography
26%
Dopaminergic
25%
Brain
22%
Cognitive Disorders
18%
Positron Emission Tomography
18%
Translocator Protein
15%
Gait
14%
Dementia
14%
Dopamine
12%
Mild Cognitive Impairment
10%
Parkinsonism
10%
L-DOPA
10%
Magnetic Resonance Imaging
9%
Temporal Lobe
9%
Putamen
8%
Neurodegeneration
8%
Radioligand
7%
Dopamine Transporter
7%
Genotype
7%
Frontal Variant Frontotemporal Dementia
7%
Dyskinesia
6%
Entorhinal Cortex
6%
Cognition
6%
Dystonia
6%
DNA Template
6%
Gene
6%
Monoamine
6%
Bradykinesia
5%
Cannabinoid 1 Receptor
5%
5-HT1A Receptor
5%